Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.6784 USD
−8.12 M USD
57.31 M USD
5.44 M
About Molecular Templates, Inc.
Sector
Industry
CEO
Eric E. Poma
Website
Headquarters
Austin
Founded
2000
FIGI
BBG000NRVRG3
Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariépy, and Leigh Revers in 2001 and is headquartered in Austin, TX.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MTEM is 0.4037 USD — it has decreased by −3.10% in the past 24 hours. Watch Molecular Templates, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Molecular Templates, Inc. stocks are traded under the ticker MTEM.
MTEM stock has risen by 27.16% compared to the previous week, the month change is a −33.91% fall, over the last year Molecular Templates, Inc. has showed a −91.61% decrease.
MTEM reached its all-time high on Apr 17, 2006 with the price of 16,803.4751 USD, and its all-time low was 0.2950 USD and was reached on Oct 14, 2024. View more price dynamics on MTEM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MTEM stock is 17.14% volatile and has beta coefficient of −0.09. Track Molecular Templates, Inc. stock price on the chart and check out the list of the most volatile stocks — is Molecular Templates, Inc. there?
Today Molecular Templates, Inc. has the market capitalization of 2.98 M, it has decreased by −20.74% over the last week.
Yes, you can track Molecular Templates, Inc. financials in yearly and quarterly reports right on TradingView.
Molecular Templates, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
MTEM earnings for the last quarter are −1.23 USD per share, whereas the estimation was −1.44 USD resulting in a 14.58% surprise. The estimated earnings for the next quarter are −1.03 USD per share. See more details about Molecular Templates, Inc. earnings.
Molecular Templates, Inc. revenue for the last quarter amounts to 572.00 K USD, despite the estimated figure of 430.00 K USD. In the next quarter, revenue is expected to reach 330.00 K USD.
MTEM net income for the last quarter is −8.10 M USD, while the quarter before that showed 572.00 K USD of net income which accounts for −1.52 K% change. Track more Molecular Templates, Inc. financial stats to get the full picture.
No, MTEM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 20, 2024, the company has 62.00 employees. See our rating of the largest employees — is Molecular Templates, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Molecular Templates, Inc. EBITDA is −13.85 M USD, and current EBITDA margin is −6.20%. See more stats in Molecular Templates, Inc. financial statements.
Like other stocks, MTEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Molecular Templates, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Molecular Templates, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Molecular Templates, Inc. stock shows the sell signal. See more of Molecular Templates, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.